A Study to Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)

Condition:   Post-kala-azar Dermal Leishmaniasis Interventions:   Biological: Vaccine;   Other: Placebo Sponsors:   University of York;   Wellcome Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials